Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency
Year: 2009
Type: article
Study design: Clinical Trial
DOI: 10.1530/eje-08-0436
Authors: G S Conway, M Szarras-Czapnik, K Racz, A Keller, P Chanson, M Tauber, M Zacharin, _ _
Institutions: University College Hospital, University College London Hospitals NHS Foundation Trust, Children's Memorial Health Institute, Semmelweis University, Leipzig University, Assistance Publique – Hôpitaux de Paris, Bicêtre Hospital, Centre Hospitalier Universitaire de Toulouse, Hôpital des Enfants, Royal Children's Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W2151739898
